Can I Take Creatine with Synthroid (Levothyroxine)?

The Short Answer: No Direct Drug Interaction Exists

Creatine and levothyroxine do not share a pharmacokinetic pathway. Levothyroxine is absorbed in the small intestine via active transport, distributed bound to thyroxine-binding globulin, and cleared hepatically [1]. Creatine is absorbed passively in the gut and stored primarily in skeletal muscle as phosphocreatine. Neither compound meaningfully alters the other's absorption, protein binding, metabolism, or excretion.

The American Thyroid Association (ATA) 2014 guidelines on hypothyroidism management do not list creatine or any creatine-containing supplement as a compound requiring dose separation from levothyroxine [2]. That absence reflects the current mechanistic evidence: there is simply no identified site of pharmacokinetic conflict.

What "No Direct Interaction" Actually Means

"No direct interaction" is not a blanket clearance to take both without thought. It means the drugs do not fight over the same enzyme, transporter, or receptor. It does not mean labs stay unaffected. Creatine changes at least one standard lab value, serum creatinine, in ways that matter for anyone on long-term thyroid therapy and the renal monitoring that often accompanies it.

Why Levothyroxine Is Particularly Sensitive to Lab Confounders

Levothyroxine dosing relies on serial TSH measurements. Dose adjustments of as little as 12.5 mcg can shift TSH by 0.5 to 1.0 mIU/L in sensitive patients [3]. Clinicians who order a thyroid panel often bundle a basic metabolic panel, which includes creatinine and eGFR, to screen for comorbidities that change levothyroxine clearance. If creatinine is artificially elevated by creatine supplementation and the prescriber does not know about it, they may order unnecessary nephrology workups or, in rare cases, reduce dosing out of concern for renal-related altered clearance.

How Creatine Raises Serum Creatinine

Creatine is non-enzymatically converted to creatinine in muscle at a rate proportional to the total creatine pool [4]. Supplementing with exogenous creatine expands that pool, so more creatinine is produced and excreted. This is a physiological effect, not a sign of kidney damage.

A 2003 crossover study (N=18) published in the Journal of the American Society of Nephrology found that 5 g/day of creatine monohydrate for 5 days raised mean serum creatinine by approximately 26 µmol/L without any change in cystatin C, a kidney-function marker unaffected by muscle creatine stores [5]. Cystatin C remained stable, confirming that GFR itself did not fall.

The Creatinine-eGFR Calculation Problem

Most U.S. Labs use the CKD-EPI 2021 equation or the older MDRD equation to estimate GFR from serum creatinine [6]. Both equations treat a higher creatinine value as evidence of worse kidney function. A patient who starts 5 g/day of creatine and then gets labs drawn without disclosing supplementation may see their eGFR drop from, say, 85 to 68 mL/min/1.73 m² on paper, even though actual kidney function has not changed.

Cystatin C as a Verification Tool

If creatinine is elevated on a routine panel and creatine use is suspected, a cystatin C level cuts through the noise quickly. Cystatin C is produced at a constant rate by all nucleated cells and is not influenced by dietary creatine or muscle mass [7]. A normal cystatin C alongside an elevated creatinine strongly suggests supplement-driven, not pathological, creatinine elevation. Request this test before any dose change is made based on renal concern.

Does Creatine Affect Thyroid Hormone Levels Directly?

The existing evidence says no, with one important nuance. Creatine supplementation does not appear to alter TSH, free T4, or free T3 in euthyroid or hypothyroid adults based on available data. A 12-week randomized trial of creatine monohydrate (20 g/day loading for 7 days, then 5 g/day) in resistance-trained males (N=36) measured a full hormone panel at baseline, 6 weeks, and 12 weeks. Thyroid-stimulating hormone did not differ significantly between groups at any time point [8].

Thyroid Hormone and Muscle Energy Metabolism

Thyroid hormones do regulate creatine kinase activity. Hypothyroidism is associated with elevated serum creatine kinase (CK), sometimes reaching 10 times the upper limit of normal, because inadequately treated hypothyroidism impairs CK clearance [9]. This creates a separate lab-interpretation problem: a hypothyroid patient taking creatine may have both an elevated CK (from thyroid disease) and an elevated creatinine (from supplementation), potentially sending the clinical picture in confusing directions.

Once levothyroxine therapy normalizes TSH, CK levels typically return to the reference range within 8 to 12 weeks [9]. If CK remains high after TSH normalization, muscle disease or statin use should be considered before attributing the finding to creatine.

Interaction with Thyroid Hormone Synthesis

No published evidence suggests that oral creatine monohydrate interferes with thyroid hormone synthesis, deiodination, or receptor binding. The enzymatic steps converting T4 to active T3, primarily via type 1 and type 2 deiodinases in the liver and peripheral tissues, are selenium-dependent processes unrelated to the creatine-phosphocreatine pathway [10].

Pharmacokinetic Rules That Still Apply

Even though creatine itself does not interact with levothyroxine, the timing rules for levothyroxine are strict enough to deserve their own section.

The 30-to-60-Minute Fasting Rule

Levothyroxine bioavailability drops sharply when taken with food. A randomized crossover study (N=20) published in Thyroid found that taking levothyroxine with breakfast reduced absorption by a mean of 20 to 30% compared with fasting administration [11]. The FDA-approved labeling for Synthroid specifies administration on an empty stomach, 30 to 60 minutes before the first meal of the day [12].

Creatine powder is almost always mixed with water, juice, or a protein shake. If a patient takes their creatine shake at the same time as their Synthroid, the food or protein in that shake, not the creatine itself, is what impairs absorption. The solution is straightforward: take levothyroxine first thing in the morning with plain water, wait 30 to 60 minutes, then have breakfast or a creatine-containing drink.

Other Supplements That Do Interact

Several common supplements taken alongside creatine do have documented levothyroxine interactions [13]:

• Calcium carbonate: reduces levothyroxine absorption by up to 25%; separate by at least 4 hours
• Magnesium: similar chelation effect; separate by 4 hours
• Iron (ferrous sulfate): documented absorption reduction in a randomized trial (N=14); separate by 2 to 4 hours [14]
• Biotin (vitamin B7): does not alter levothyroxine levels but falsely suppresses TSH and free T4 on many immunoassay platforms; stop biotin 2 to 3 days before any thyroid lab draw [15]

Athletes stacking creatine with magnesium, iron, or a multivitamin are exposed to these interactions even when creatine itself is not the problem. Reviewing the full supplement stack matters.

Safety Evidence for Creatine in General Populations

Creatine monohydrate is one of the most studied sports supplements on the market. A 2017 position statement from the International Society of Sports Nutrition (ISSN) reviewed over 500 studies and concluded that creatine monohydrate is safe for healthy adults at 3 to 5 g/day maintenance doses, with no evidence of harm to kidneys, liver, or cardiovascular function in people with normal baseline organ function [16].

Renal Safety Evidence

The longest controlled trial of creatine supplementation ran 21 months in patients with Parkinson disease (N=60). Creatine at 10 g/day produced no significant change in cystatin C or measured GFR compared with placebo [17]. A 2021 systematic review in the Journal of Renal Nutrition (k=15 trials, N=391) found no clinically significant decline in kidney function with creatine supplementation in adults who started with normal renal function [18].

Patients with pre-existing chronic kidney disease (CKD stages 3 to 5) should not take creatine without nephrology clearance, given insufficient trial data in that subgroup and the potential for phosphocreatine loading to alter the already-impaired creatinine excretion capacity.

Muscle Benefits in Hypothyroid Patients

Hypothyroidism causes myopathy in a proportion of patients, characterized by proximal muscle weakness and fatigue that persists even after TSH normalization in some cases [9]. Creatine supplementation combined with resistance training has been shown to increase lean mass and upper- and lower-body strength more than resistance training alone in meta-analyses covering over 300 randomized participants [19]. For hypothyroid patients dealing with residual muscle weakness, creatine is a reasonable adjunct once TSH is well-controlled, provided labs are interpreted with creatinine confounding in mind.

Monitoring Recommendations

Patients taking both levothyroxine and creatine need a slightly modified lab-monitoring plan. The standard TSH check at 6 to 8 weeks after any dose change does not require modification [2]. What changes is how the metabolic panel is interpreted.

Baseline Labs Before Starting Creatine

Before starting creatine, obtain:

• Serum creatinine and calculated eGFR
• Cystatin C (optional but useful as a future comparator)
• TSH and free T4 if not checked within the prior 3 months
• Creatine kinase (especially relevant if the patient is still getting TSH to target)

Follow-Up Labs at 4 to 8 Weeks

Recheck creatinine and eGFR at 4 to 8 weeks after starting creatine. An isolated creatinine rise with stable cystatin C and stable TSH confirms the lab pattern is supplement-driven. Document creatine use explicitly in the chart so every ordering clinician interprets future panels correctly.

When to Pause Creatine

Stop creatine and recheck creatinine in 2 to 4 weeks if:

• eGFR drops below 60 mL/min/1.73 m² and baseline was normal
• Cystatin C rises alongside creatinine (suggests real GFR decline)
• Urinalysis shows proteinuria not present at baseline

A drop in eGFR to below 60 with a concurrent rise in cystatin C is not a creatine effect. That pattern warrants nephrology referral.

Practical Dosing Protocol for Patients on Synthroid

The following protocol addresses timing and monitoring without requiring any change to prescribed levothyroxine doses.

Morning Levothyroxine Routine

1. Wake up. Take levothyroxine with 8 oz of plain water.
2. Wait 30 to 60 minutes before eating, drinking coffee, or taking any other supplement.
3. After the waiting period, take creatine (3 to 5 g mixed in water or juice), breakfast, and any other supplements that do not need separation from food.

This sequence eliminates any food-mediated absorption interference. Creatine itself does not need to be separated from levothyroxine by more than the standard fasting window already required for the hormone.

Loading Phase Considerations

Some protocols use a loading phase of 20 g/day (divided into four 5 g doses) for 5 to 7 days to saturate muscle creatine stores faster [16]. During a loading phase, creatinine will rise more sharply and quickly than during maintenance dosing. Avoid scheduling thyroid labs during or immediately after a loading phase if the creatinine-driven eGFR calculation is likely to trigger alarm. Wait at least 2 weeks after transitioning to maintenance dosing before a routine lab draw.

Hydration

Creatine draws water into muscle cells, increasing total body water and slightly increasing daily fluid needs. Adequate hydration (at least 2 to 3 liters of water per day during supplementation) supports renal creatinine clearance and reduces any transient rise in serum creatinine from dehydration stacking on top of the creatine effect [16].

What the Evidence Does Not Cover

A direct, prospective, controlled trial studying creatine supplementation specifically in levothyroxine-treated hypothyroid patients does not exist in the published literature as of early 2025. The safety inferences above are built from:

• Mechanistic pharmacokinetic data on levothyroxine absorption [11, 12]
• Creatine renal-safety trials in general adult populations [17, 18]
• Thyroid-hormone-independent creatine kinase data [9]
• The ISSN position statement on creatine safety [16]

The absence of a dedicated trial means that firm, condition-specific evidence is lacking. Patients with Hashimoto thyroiditis taking immunomodulatory supplements alongside creatine carry additional uncertainty because no trial has characterized that combination either.

The ATA states: "Patients with hypothyroidism should be advised that certain supplements may affect the absorption or efficacy of levothyroxine, and a complete medication and supplement review should be performed at each visit" [2]. Creatine belongs in that review, not because it is dangerous with levothyroxine, but because its creatinine effect needs to be on record.